ROSEFINCH LifeSciences is a private specialty pharmaceutical company dedicated to improving people’s health through the development and commercialization of innovative products for various medical conditions.

As a Proof of the outstanding productivity of our core expertise is the speed at which we are progressing our pipeline of six therapeutic programs, addressing cancer, autoimmune and inflammatory indications, into preclinical development.